Abiopharma

KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)

Symbol	KMTS
Name	KESTRA MEDICAL TECHNOLOGIES, LTD.
Sector	HEALTH CARE
Region	North America
Industry	Medical/Dental Instruments
Address	3933 LAKE WASHINGTON BLVD NE,SUITE 200, KIRKLAND, Washington, 98033, United States
Telephone	+1 425 279-8002
Fax	—
Email	—
Website	https://www.kestramedical.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001877184
Description	Kestra Medical Technologies is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of our Cardiac Recovery System platform is the ASSURE WCD, a next generation wearable cardioverter defibrillator used to protect patients at an elevated risk of sudden cardiac arrest. The ASSURE WCD automatically monitors elevated risk patients and, if needed, delivers a defibrillation shock to return the patients heart to normal rhythm. Additional info from NASDAQ: Kestra Medical Technologies is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of our Cardiac Recovery System platform is the ASSURE WCD, a next generation wearable cardioverter defibrillator used to protect patients at an elevated risk of sudden cardiac arrest. The ASSURE WCD automatically monitors elevated risk patients and, if needed, delivers a defibrillation shock to return the patients heart to normal rhythm.

2026-06-30 20:05

Kestra Medical Technologies to Report Fourth Quarter Fiscal 2026 Financial Results on July 14

2026-06-17 20:36

Webster Brian Daniel 🔴 sold 15.0K shares of KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) at $20.81 Transaction Date: Jun 15, 2026 | Filing ID: 274257

2026-06-15 21:10

📋 Webster Brian Daniel (Officer) plans to sell 15K shares of KESTRA MEDICAL TECHNOLOGIES, LTD. (at $20.81 each, total $312K) Filed: Jun 15, 2026 | ID: 000289

2026-06-04 22:40

Moran Timothy P. 🟢 acquired 22.7K shares of KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) Transaction Date: Jun 03, 2026 | Filing ID: 257915

2026-06-04 22:39

Ford Alfred J Jr 🟢 acquired 25.2K shares of KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) Transaction Date: Jun 03, 2026 | Filing ID: 257913

2026-06-04 22:37

Mahboob Vaseem 🟢 acquired 25.2K shares of KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) Transaction Date: Jun 03, 2026 | Filing ID: 257911

2026-06-04 22:36

Umberger Traci S 🟢 acquired 25.2K shares of KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) Transaction Date: Jun 03, 2026 | Filing ID: 257908

2026-06-04 22:35

Webster Brian Daniel 🟢 acquired 75.7K shares of KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) Transaction Date: Jun 03, 2026 | Filing ID: 257907

2026-05-18 21:40

Webster Brian Daniel 🔴 sold 15.0K shares of KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) at $21.46 Transaction Date: May 15, 2026 | Filing ID: 229188

2026-05-15 20:15

📋 Webster Brian Daniel (Officer) plans to sell 15K shares of KESTRA MEDICAL TECHNOLOGIES, LTD. (at $20.96 each, total $314K) Filed: May 15, 2026 | ID: 000243

Trial ID	Title	Phase	Indication	Status	Start Date	Completion Date	Source
NCT05135403	ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS)	—	Sudden Cardiac Arrest	Recruiting	2021-11-20	2025-10-01	ClinicalTrials.gov
NCT04132466	ASSURE WCD Clinical Evaluation - Conversion Efficacy Study	Na	Death, Sudden, Cardiac	Completed	2019-11-25	2020-03-19	ClinicalTrials.gov
NCT03887052	ASSURE WCD Clinical Evaluation - Detection and Safety Study	Na	Cardiac Arrest, Sudden	Completed	2019-03-20	2019-06-18	ClinicalTrials.gov

Total clinical trials: 3

Product Name	Type	Development Stage	Therapeutic Area	Study Status	Trial ID
Defibrillation	Other	Preclinical	Sudden Cardiac Arrest	RECRUITING	NCT05135403
ASSURE™ Wearable Cardioverter Defibrillator (WCD)	Other	Approved	Cardiac Arrest, Sudden	COMPLETED	NCT03887052
Defibrillation using the ASSURE wearable cardioverter defibrillator therapy delivered via a waveform delivery test system	Drug	Approved	Death, Sudden, Cardiac	COMPLETED	NCT04132466

Total products: 3